425 related articles for article (PubMed ID: 16385628)
21. Impact of Toll-like receptor signalling on urinary tract infection.
Scherberich JE; Hartinger A
Int J Antimicrob Agents; 2008 Feb; 31 Suppl 1():S9-14. PubMed ID: 17942281
[TBL] [Abstract][Full Text] [Related]
22. The expanding family of MyD88-like adaptors in Toll-like receptor signal transduction.
McGettrick AF; O'Neill LA
Mol Immunol; 2004 Jul; 41(6-7):577-82. PubMed ID: 15219996
[TBL] [Abstract][Full Text] [Related]
23. Innate immunity to mycobacterial infection in mice: critical role for toll-like receptors.
Ryffel B; Fremond C; Jacobs M; Parida S; Botha T; Schnyder B; Quesniaux V
Tuberculosis (Edinb); 2005; 85(5-6):395-405. PubMed ID: 16257265
[TBL] [Abstract][Full Text] [Related]
24. TLR- and CXCR1-dependent innate immunity: insights into the genetics of urinary tract infections.
Ragnarsdóttir B; Fischer H; Godaly G; Grönberg-Hernandez J; Gustafsson M; Karpman D; Lundstedt AC; Lutay N; Rämisch S; Svensson ML; Wullt B; Yadav M; Svanborg C
Eur J Clin Invest; 2008 Oct; 38 Suppl 2():12-20. PubMed ID: 18826477
[TBL] [Abstract][Full Text] [Related]
25. Signal transduction by the lipopolysaccharide receptor, Toll-like receptor-4.
Pålsson-McDermott EM; O'Neill LA
Immunology; 2004 Oct; 113(2):153-62. PubMed ID: 15379975
[TBL] [Abstract][Full Text] [Related]
26. Mycobacterium paratuberculosis is recognized by Toll-like receptors and NOD2.
Ferwerda G; Kullberg BJ; de Jong DJ; Girardin SE; Langenberg DM; van Crevel R; Ottenhoff TH; Van der Meer JW; Netea MG
J Leukoc Biol; 2007 Oct; 82(4):1011-8. PubMed ID: 17652449
[TBL] [Abstract][Full Text] [Related]
27. TICAM-1 and TICAM-2: toll-like receptor adapters that participate in induction of type 1 interferons.
Seya T; Oshiumi H; Sasai M; Akazawa T; Matsumoto M
Int J Biochem Cell Biol; 2005 Mar; 37(3):524-9. PubMed ID: 15618008
[TBL] [Abstract][Full Text] [Related]
28. Differential induction of MyD88- and TRIF-dependent pathways in equine monocytes by Toll-like receptor agonists.
Figueiredo MD; Vandenplas ML; Hurley DJ; Moore JN
Vet Immunol Immunopathol; 2009 Jan; 127(1-2):125-34. PubMed ID: 19019456
[TBL] [Abstract][Full Text] [Related]
29. Uropathogenic Escherichia coli as a model of host-parasite interaction.
Svanborg C; Bergsten G; Fischer H; Godaly G; Gustafsson M; Karpman D; Lundstedt AC; Ragnarsdottir B; Svensson M; Wullt B
Curr Opin Microbiol; 2006 Feb; 9(1):33-9. PubMed ID: 16406777
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of TIR domain signaling by TcpC: MyD88-dependent and independent effects on Escherichia coli virulence.
Yadav M; Zhang J; Fischer H; Huang W; Lutay N; Cirl C; Lum J; Miethke T; Svanborg C
PLoS Pathog; 2010 Sep; 6(9):e1001120. PubMed ID: 20886104
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of homodimerization of Toll-like receptor 4 by curcumin.
Youn HS; Saitoh SI; Miyake K; Hwang DH
Biochem Pharmacol; 2006 Jun; 72(1):62-9. PubMed ID: 16678799
[TBL] [Abstract][Full Text] [Related]
32. Antagonism between MyD88- and TRIF-dependent signals in B7RP-1 up-regulation.
Zhou Z; Hoebe K; Du X; Jiang Z; Shamel L; Beutler B
Eur J Immunol; 2005 Jun; 35(6):1918-27. PubMed ID: 15884053
[TBL] [Abstract][Full Text] [Related]
33. The human adaptor SARM negatively regulates adaptor protein TRIF-dependent Toll-like receptor signaling.
Carty M; Goodbody R; Schröder M; Stack J; Moynagh PN; Bowie AG
Nat Immunol; 2006 Oct; 7(10):1074-81. PubMed ID: 16964262
[TBL] [Abstract][Full Text] [Related]
34. Toll/IL-1 receptor domain-containing adaptor inducing IFN-beta (TRIF)-mediated signaling contributes to innate immune responses in the lung during Escherichia coli pneumonia.
Jeyaseelan S; Young SK; Fessler MB; Liu Y; Malcolm KC; Yamamoto M; Akira S; Worthen GS
J Immunol; 2007 Mar; 178(5):3153-60. PubMed ID: 17312163
[TBL] [Abstract][Full Text] [Related]
35. MAPPIT analysis of early Toll-like receptor signalling events.
Ulrichts P; Tavernier J
Immunol Lett; 2008 Mar; 116(2):141-8. PubMed ID: 18221795
[TBL] [Abstract][Full Text] [Related]
36. Dissemination of Toxoplasma gondii to immunoprivileged organs and role of Toll/interleukin-1 receptor signalling for host resistance assessed by in vivo bioluminescence imaging.
Hitziger N; Dellacasa I; Albiger B; Barragan A
Cell Microbiol; 2005 Jun; 7(6):837-48. PubMed ID: 15888086
[TBL] [Abstract][Full Text] [Related]
37. Pathological role of Toll-like receptor signaling in cerebral malaria.
Coban C; Ishii KJ; Uematsu S; Arisue N; Sato S; Yamamoto M; Kawai T; Takeuchi O; Hisaeda H; Horii T; Akira S
Int Immunol; 2007 Jan; 19(1):67-79. PubMed ID: 17135446
[TBL] [Abstract][Full Text] [Related]
38. TNF receptor-associated factor-1 (TRAF1) negatively regulates Toll/IL-1 receptor domain-containing adaptor inducing IFN-beta (TRIF)-mediated signaling.
Su X; Li S; Meng M; Qian W; Xie W; Chen D; Zhai Z; Shu HB
Eur J Immunol; 2006 Jan; 36(1):199-206. PubMed ID: 16323247
[TBL] [Abstract][Full Text] [Related]
39. Evolution and integration of innate immune recognition systems: the Toll-like receptors.
Takeda K
J Endotoxin Res; 2005; 11(1):51-5. PubMed ID: 15826379
[TBL] [Abstract][Full Text] [Related]
40. Type 1 fimbriae deliver an LPS- and TLR4-dependent activation signal to CD14-negative cells.
Hedlund M; Frendéus B; Wachtler C; Hang L; Fischer H; Svanborg C
Mol Microbiol; 2001 Feb; 39(3):542-52. PubMed ID: 11169097
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
